The company has successfully scaled its total assets from $677.5 billion in 2024Q4 to $743.2 billion by 2026Q1, though equity remains constrained at $27.3 billion due to ongoing reserve requirements.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 |
|---|
| Total Assets | 743.21B | 745.17B | 677.46B | 687.58B | 663.07B | 759.71B | 795.15B | 740.46B | 687.54B | 719.89B | 898.76B | 877.93B | 902.34B | 885.3B | 836.78B | 799.63B | 730.91B | 539.31B | 501.68B | 559.15B | 527.72B | 481.64B | 356.81B | 326.84B | 277.43B | 256.97B | 254.16B | 225.23B | 215.35B |
| Asset Growth % | 24.02% | 9.99% | -1.47% | 3.7% | -12.72% | -4.46% | 7.38% | 7.7% | -4.49% | -19.9% | 2.37% | -2.7% | 1.92% | 5.8% | 4.65% | 9.4% | 35.53% | 7.5% | -10.28% | 5.96% | 9.57% | 34.99% | 9.17% | 17.81% | 7.96% | 1.1% | 12.84% | 4.59% | - |
| Total Investment Assets | 4M | 466.11B | 435.38B | 440.38B | 427.95B | 494.82B | 508.52B | 473.8B | 436.21B | 444.07B | 420.91B | 495.46B | 506B | 488.78B | 517.05B | 511.38B | 471.06B | 334.46B | 305.9B | 324.81B | 60.27B | 47.17B | 41.3B | 35B | 33.67B | 31.89B | 30.11B | 0 | 0 |
| Long-Term Investments | 1.69T | 362.81B | 346.67B | 144.19B | 134.83B | 147.37B | 382.58B | 353.83B | 322.87B | 338.77B | 304.12B | 371.12B | 386.42B | 375.61B | 401.41B | 377.45B | 358.87B | 241.48B | 206.27B | 241.57B | 7.8B | 236.69B | 181.61B | 171.18B | 143.82B | 119.66B | 116.44B | 0 | 0 |
| Short-Term Investments | 316.11B | 103.31B | 88.71B | 296.19B | 293.13B | 347.45B | 358.71B | 331.67B | 302.2B | 313.8B | 298.98B | 364.02B | 377.68B | 367.54B | 394.06B | 370.6B | 9.39B | 8.37B | 13.88B | 2.54B | 2.71B | 3.31B | 2.66B | 1.83B | 1.92B | 1.2B | 1.27B | 0 | 0 |
| Total Current Assets | 73.02B | 179.59B | 143.04B | 350.62B | 335.49B | 388.01B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 22.69B | 22.03B | 20.07B | 20.64B | 20.2B | 20.05B | 19.8B | 16.6B | 15.82B | 12.7B | 12.65B | 12.75B | 10.81B | 7.58B | 15.74B | 10.46B | 13.05B | 10.11B | 24.21B | 9.96B | 7.11B | 4.02B | 4.05B | 3.73B | 2.32B | 7.47B | 3.43B | 2.79B | 0 |
| Receivables | 186.1B | 54.25B | 34.26B | 33.78B | 22.17B | 20.52B | 17.87B | 20.44B | 19.64B | 18.42B | 15.46B | 22.86B | 22.24B | 21.86B | 21.63B | 22.48B | 19.83B | 17.07B | 16.97B | 13.37B | 14.49B | 12.19B | 6.7B | 7.05B | 7.67B | 6.44B | 8.34B | 0 | 0 |
| Other Current Assets | -316.11B | 0 | 0 | 0 | 0 | 0 | -396.38B | -368.71B | -337.67B | -344.93B | -327.1B | -399.64B | -410.73B | -396.99B | -431.44B | -403.55B | -42.26B | -35.55B | -55.06B | -25.88B | -24.31B | -19.51B | -13.41B | -12.61B | -11.91B | -15.11B | -13.05B | 0 | 0 |
| Goodwill & Intangibles | 100.69B | 30.72B | 28.53B | 29.39B | 28.95B | 25.6B | 10.11B | 9.31B | 9.42B | 9.59B | 9.22B | 9.48B | 9.87B | 10.54B | 9.95B | 11.94B | 11.78B | 5.05B | 5.01B | 4.81B | 4.9B | 4.8B | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 9.56B | 9.61B | 8.9B | 9.24B | 9.3B | 9.54B | 10.11B | 9.31B | 9.42B | 9.59B | 9.22B | 9.48B | 9.87B | 10.54B | 9.95B | 11.94B | 11.78B | 5.05B | 5.01B | 4.81B | 4.9B | 4.8B | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 21.11B | 19.63B | 20.15B | 19.65B | 16.06B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.8B | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PP&E (Net) | 0 | 1.7B | 1.85B | 1.99B | 1.93B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 39.83B | 167.77B | 154.38B | 158.79B | 159.44B | 198.54B | -392.69B | -363.14B | -332.29B | -348.36B | -313.34B | -380.6B | -396.29B | -386.15B | -411.36B | -389.39B | -370.65B | -246.53B | -211.28B | -246.38B | -12.7B | -241.49B | -181.61B | -171.18B | -143.82B | -119.66B | -116.44B | 0 | 0 |
| Total Liabilities | 715.41B | 716.25B | 649.75B | 657.33B | 632.95B | 691.96B | 720.33B | 674.08B | 634.58B | 661.02B | 831.06B | 809.44B | 829.68B | 822.31B | 771.82B | 748.43B | 681.79B | 505.82B | 477.69B | 523.97B | 493.92B | 452.54B | 333.98B | 305.69B | 258.78B | 239.65B | 236.68B | 211.54B | 200.48B |
| Total Debt | 20.29B | 20.18B | 18.71B | 18.83B | 17.98B | 17.43B | 18.15B | 16.85B | 16.24B | 19.31B | 19.85B | 21.32B | 19.58B | 22.02B | 22.39B | 27.57B | 36.38B | 22.62B | 16.08B | 13.84B | 14.36B | 13.44B | 8.86B | 9.35B | 5.59B | 3.98B | 3.44B | 6.67B | 3.57B |
| Net Debt | -2.4B | -1.85B | -1.35B | -1.81B | -2.21B | -2.62B | -1.65B | 253M | 423M | 6.61B | 7.2B | 8.56B | 8.77B | 14.44B | 6.65B | 17.11B | 23.33B | 12.51B | -8.12B | 3.88B | 7.25B | 9.42B | 4.81B | 5.61B | 3.26B | -3.49B | 4M | 3.88B | 3.57B |
| Long-Term Debt | 19.89B | 18.62B | 18.24B | 18.68B | 17.75B | 17.09B | 17.76B | 16.62B | 15.98B | 18.83B | 19.61B | 21.22B | 19.48B | 21.85B | 22.25B | 26.85B | 36.07B | 21.71B | 13.43B | 13.18B | 12.91B | 12.02B | 7.41B | 5.7B | 4.42B | 3.63B | 2.35B | 2.49B | 0 |
| Short-Term Debt | 404M | 1.56B | 465M | 119M | 175M | 341M | 393M | 235M | 268M | 477M | 242M | 100M | 100M | 175M | 100M | 686M | 306M | 912M | 2.66B | 667M | 1.45B | 1.41B | 1.45B | 3.64B | 1.16B | 355M | 1.08B | 4.18B | 3.57B |
| Total Current Liabilities | 859M | 276.14B | 258.07B | 257.57B | 251.08B | 263.18B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 789M | 2.02B | 917M | 1.07B | 1.05B | 18.89B | 13.71B | 13.38B | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 455M | 257.46B | 240.48B | 239.93B | 229.97B | 230.92B | -1.11B | -1.28B | -1.39B | -1.47B | -938M | -820M | -968M | -1.04B | -1.23B | -1.65B | -622M | -1.67B | -4.02B | -1.46B | -4.94B | -2.4B | -2.94B | -5.34B | -20.82B | -14.37B | -14.58B | -4.18B | -3.57B |
| Deferred Taxes | 1.92B | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 0 | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 0 |
| Other Liabilities | 695.14B | 420.95B | 373.3B | 380.12B | 363.11B | 402B | -28.76B | -25.71B | -21.39B | -25.6B | -26.5B | -31.81B | -31.3B | -28.49B | -30.98B | -33.28B | -36.07B | -21.71B | -13.43B | -14.68B | -15.19B | -13.73B | -9.88B | -8.1B | -6.05B | -5.15B | -3.1B | -2.49B | 0 |
| Total Equity | 27.8B | 28.92B | 27.7B | 30.25B | 30.13B | 67.75B | 74.82B | 66.38B | 52.96B | 58.87B | 67.7B | 68.5B | 72.66B | 62.98B | 64.96B | 58B | 49.11B | 33.5B | 23.73B | 35.18B | 33.8B | 29.1B | 22.82B | 21.15B | 18.65B | 17.32B | 17.48B | 13.69B | 14.87B |
| Equity Growth % | -0.36% | 4.4% | -8.43% | 0.42% | -55.53% | -9.45% | 12.71% | 25.35% | -10.04% | -13.05% | -1.16% | -5.73% | 15.36% | -3.04% | 12% | 18.09% | 46.61% | 41.14% | -32.53% | 4.09% | 16.14% | 27.5% | 7.92% | 13.4% | 7.69% | -0.92% | 27.68% | -7.92% | - |
| Shareholders Equity | 27.32B | 28.4B | 27.45B | 30.02B | 29.88B | 67.48B | 74.56B | 66.14B | 52.74B | 58.68B | 67.53B | 67.95B | 72.05B | 61.55B | 64.45B | 57.52B | 48.63B | 33.12B | 23.73B | 35.18B | 33.8B | 29.1B | 22.82B | 21.15B | 17.39B | 16.06B | 16.39B | 13.69B | 14.87B |
| Minority Interest | 477M | 523M | 258M | 238M | 244M | 267M | 259M | 238M | 217M | 194M | 171M | 547M | 606M | 1.43B | 505M | 479M | 488M | 377M | 0 | 0 | 0 | 0 | 0 | 0 | 1.26B | 1.26B | 1.09B | 0 | 0 |
| Retained Earnings | 45.06B | 44.29B | 42.63B | 40.15B | 40.33B | 41.2B | 36.49B | 33.08B | 28.93B | 26.53B | 34.68B | 35.52B | 32.02B | 27.33B | 25.2B | 24.81B | 21.36B | 19.5B | 22.4B | 19.88B | 16.57B | 10.87B | 6.61B | 4.19B | 2.81B | 1.35B | 1.02B | 14.1B | 13.48B |
| Common Stock | 12M | 12M | 12M | 12M | 12M | 12M | 12M | 12M | 12M | 12M | 12M | 12M | 12M | 11M | 11M | 11M | 10M | 8M | 8M | 8M | 8M | 8M | 8M | 8M | 8M | 8M | 8M | 0 | 0 |
| Accumulated OCI | -19.23B | -18.08B | -21.19B | -19.24B | -22.62B | 10.92B | 18.07B | 13.05B | 1.72B | 7.43B | 5.37B | 4.77B | 10.65B | 5.1B | 11.4B | 5.89B | 1B | -3.06B | -14.25B | 1.08B | 1.12B | 1.91B | 2.96B | 2.79B | 2.01B | 1.67B | 1.05B | -410M | 1.38B |
| Return on Equity (ROE) | 12.72% | 11.93% | 15.27% | 5.23% | 10.8% | 9.62% | 7.66% | 9.89% | 9.16% | 6.34% | 1.25% | 7.61% | 9.3% | 5.26% | 2.15% | 11.99% | 6.46% | -7.85% | 10.89% | 12.52% | 20.01% | 18.16% | 12.54% | 11.14% | 8.92% | 2.72% | 6.12% | 4.32% | 9.03% |
| Return on Assets (ROA) | 0.5% | 0.47% | 0.65% | 0.23% | 0.74% | 0.88% | 0.7% | 0.83% | 0.73% | 0.5% | 0.1% | 0.6% | 0.71% | 0.39% | 0.16% | 0.84% | 0.42% | -0.43% | 0.6% | 0.79% | 1.25% | 1.12% | 0.81% | 0.73% | 0.6% | 0.19% | 0.4% | 0.28% | 0.62% |
| Equity / Assets | 3.74% | 3.88% | 4.09% | 4.4% | 4.54% | 8.92% | 9.41% | 8.96% | 7.7% | 8.18% | 7.53% | 7.8% | 8.05% | 7.11% | 7.76% | 7.25% | 6.72% | 6.21% | 4.73% | 6.29% | 6.4% | 6.04% | 6.4% | 6.47% | 6.72% | 6.74% | 6.88% | 6.08% | 6.9% |
| Debt / Equity | 0.73x | 0.70x | 0.68x | 0.62x | 0.60x | 0.26x | 0.24x | 0.25x | 0.31x | 0.33x | 0.29x | 0.31x | 0.27x | 0.35x | 0.34x | 0.48x | 0.74x | 0.68x | 0.68x | 0.39x | 0.42x | 0.46x | 0.39x | 0.44x | 0.30x | 0.23x | 0.20x | 0.49x | 0.24x |
| Book Value per Share | 42.40 | 43.49 | 38.96 | 39.68 | 37.24 | 77.93 | 81.93 | 70.29 | 52.23 | 56.41 | 61.80 | 60.70 | 64.19 | 56.13 | 59.50 | 54.82 | 49.82 | 40.93 | 31.87 | 46.15 | 43.85 | 38.54 | 30.23 | 28.31 | 25.56 | 22.70 | 27.33 | 17.50 | 19.00 |
| Tangible BV per Share | 27.81 | -2.71 | -1.16 | 1.14 | 1.45 | 48.49 | 70.86 | 60.43 | 42.94 | 47.22 | 53.38 | 52.31 | 55.47 | 46.74 | 50.39 | 43.54 | 37.87 | 34.76 | 25.14 | 39.84 | 37.50 | 25.84 | 30.23 | 28.31 | 25.56 | 22.70 | 27.33 | 17.50 | 19.00 |
Legacy block reserve volatility
As reported in recent financial statements, MetLife's total assets grew from $677.5 billion in 2024Q4 to $743.2 billion by 2026Q1, suggesting that the company is successfully scaling its balance sheet despite the inherent cyclicality of its global insurance operations and the ongoing transition to LDTI accounting standards.
The expansion in total assets appears to be driven by both organic growth in core segments and the impact of updated liability discounting under new accounting rules. Investors should monitor whether this asset growth is matched by a commensurate improvement in capital efficiency or if it merely reflects the accumulation of long-duration liabilities.
Based on quarterly data, MetLife's claims and loss reserves reached a peak of $16.5 billion in 2025Q4, indicating that the firm's liability profile remains sensitive to actuarial adjustments and the potential for adverse development within its legacy long-term care and variable annuity blocks.
The volatility in reserve levels suggests that the company's equity base, which stood at $27.3 billion in 2026Q1, may be subject to periodic pressure from reserve strengthening. This warrants further investigation into the adequacy of current reserves relative to long-term inflation expectations for medical and disability claims.
According to the provided balance sheet figures, MetLife's equity remained relatively stable, moving from $30.9 billion in 2024Q3 to $27.3 billion in 2026Q1, which suggests that management is effectively balancing capital retention with the ongoing requirements of its institutional pension risk transfer and group benefits businesses.
The relative stability of the equity base despite significant asset growth indicates a disciplined approach to capital management. However, the narrowing gap between assets and liabilities suggests that the company's capital buffer may be increasingly sensitive to market-driven fluctuations in the value of its investment portfolio.
As indicated by the persistent presence of the MetLife Holdings segment, the company's balance sheet remains exposed to legacy risks that may not be fully captured by core operational metrics, potentially creating hidden volatility in the firm's long-term capital adequacy and overall solvency profile.
The legacy run-off blocks represent a non-obvious risk that could necessitate future capital injections, potentially diverting resources from higher-growth areas like institutional asset management. Investors should monitor the impact of these legacy liabilities on the company's ability to maintain its current pace of share repurchases.
Quick answers to the most common questions about buying MET stock.
As of 2025, MetLife, Inc. (MET) had total assets of $745.17B including $179.59B in current assets.
MetLife, Inc. (MET) carries total debt of $20.18B, offset by $125.34B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
MetLife, Inc. (MET) has total shareholders' equity (book value) of $28.40B ($43.49 book value per share). Book value represents the net worth of the company belonging to common stock holders.
MetLife, Inc. (MET) reported a current ratio of 0.65x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.